Skip to main content
. 2023 Jan 24;11(1):e04437-22. doi: 10.1128/spectrum.04437-22

FIG 1.

FIG 1

MIC distribution of ceftazidime-avibactam (CZA), ceftolozane-tazobactam (C/T), and cefiderocol (FDC) for 66 Pseudomonas aeruginosa isolates. Breakpoints determined by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) were used to define bacterial isolates as resistant (R) or susceptible (S).